Flavonoids as Multi-target Inhibitors for Proteins Associated with Ebola Virus: In Silico Discovery Using Virtual Screening and Molecular Docking Studies
Tóm tắt
Từ khóa
Tài liệu tham khảo
Adrian M et al (2003) A current review of Ebola virus: pathogenesis, clinical presentation, and diagnostic assessment. Biol Res Nurs 4:268
Towner JS et al (2008) Newly discovered ebola virus associated with haemorrhagic fever outbreak in Uganda. PLoS Pathog 4:e1000212
Dixon MP, Pau RN, Howlett GJ, Dunstan DE, Sawyer WH, Davidson BE (2002) Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association. J Biol Chem 277:23186–23192
International Commission (1978) Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ 56(2):271–293
Hartlieb B, Modrof J, Mühlberger E, Klenk HD, Becker S (2003) Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association. J BiolChem 278:41830–41836
Hoenen T, Groseth A, Kolesnikova L, Theriault S, Ebihara H, Hartlieb B, Bamberg S, Feldmann H, Stroher U, Becker S (2011) Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association. J Virol 80:7260–7264
Saphire EO, Lee JE, Fusco ML, Hessell AJ, Oswald WB, Burton DR (2008) Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454:177–182
Weik M, Modrof J, Klenk HD, Becker S, Muhlberger E (2002) Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleo capsid association. J Virol 76:8532–8539
Hulo C, de Castro E, Masson P, Bougueleret L, Bairoch A, Xenarios I, Le Mercier P (2011) ViralZone: a knowledge resource to understand virus diversity. Nucleic Acids Res 39:576–582
Nanbo A, Watanabe S, Halfmann P, Kawaoka Y (2013) The spatio-temporal distribution dynamics of Ebola virus proteins and RNA in infected cells. Nature 10:1038
Gomis Rüth FX (2003) The matrix protein VP40 from Ebola virus octamerizes into pore-like structures with specific RNA binding properties. Structure 11:423
Ruigrok RW et al (2000) Structural characterization and membrane binding properties of the matrix protein VP40 of Ebola virus. J Mol Biol 300:103
Volchkov Victor E et al (2011) Conserved proline-rich region of Ebola virus matrix protein VP40 is essential for plasma membrane targeting and virus-like particle release. J Infect Dis 204(suppl 3):884–891
Basler CF, Mikulasova A, Martinez-Sobrido L, Paragas J, Mühlberger E, Bray M, Klenk HD, Palese P, García-Sastre A (2003) The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol 77:7945–7956
Jin H, Yan Z, Prabhakar BS, Feng Z, Ma Y, Verpooten D, Ganesh B, He B (2010) VP35 protein of Ebola virus impairs dendritic cell maturation induced by virus and lipopolysaccharide. J Gen Virol 91:352–361
Ebihara H, Takada A, Kobasa D et al (2006) Molecular determinants of Ebola virus virulence in mice. PLoS Pathog 2:e73
Watanabe S, Noda T, Halfmann P, Jasenosky L, Kawaoka Y (2007) Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genome. J Infect Dis 196
Hoenen T, Jung S, Herwig A, Groseth A, Becker S (2010) Both matrix proteins of Ebola virus contribute to the regulation of viral genome replication and transcription. Virology 403:56–66
Huang Y, Xu L, Sun Y, Nabel GJ (2002) The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein. Mol Cell 10:307–316
Mühlberger E, Weik M, Volchkov VE, Klenk H-D, Becker S (1999) Comparison of the transcription and replication strategies of Marburg virus and Ebola virus by using artificial replication systems. J Virol 73:2333–2342
Rajamani R, Good AC (2007) Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development. Curr Opin Drug Discov Dev 10:308–315
Zeitlin L et al (2014) Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 514:47–53
Bavari S et al (2014) Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Nature 508:402–405
Cushnie TP, Lamb AJ (2011) Recent advances in understanding the antibacterial properties of flavonoids. Int J Antimicrob Agents 38(2):99–107
González R, Ballester I et al (2011) Effects of flavonoids and other polyphenols on inflammation. Crit Rev Food Sci Nutr 51(4):331–362
Nishiumi S, Miyamoto S et al (2011) Dietary flavonoids as cancer-preventive and therapeutic bio factors. Front Biosci (Sch Ed) 3:1332–1362
Sastry GM, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27(3):221–234
Halgren T (2009) Identifying and characterizing binding sites and assessing druggability. J Chem Inf Model 49:377–389
Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47:1750–1759
Shaw DE, Lindorff-Larsen K, Piana S, Palmo K, Maragakis P, Klepeis JL, Dror RO (2010) Improved side-chain torsion potentials for the amber ff99SB protein force field. Proteins: Struct Funct Bioinform 78(8):1950–1958
Mounnissamy VM, Kavimani S, Gunasegaran R (2002) Antibacterial activity of gossypetin isolated from hibiscus sabdariffa. Antiseptic 99(3):81–82
Todorov D, Hinkov A, Shishkova K, Shishkov S (2014) Antiviral potential of Bulgarian medicinal plants. Phytochem Rev 014-9357-1
Willför S, Ali M, Karonen M, Reunanen M, Arfan M, Harlamow R (2009) Extractives in bark of different conifer species growing in Pakistan. Holzforschung 63(5):551–558
Shi Q, Li C, Huo C, Zhang M (2007) Chemistry of Chinese yew, Taxus chinensis var. mairei. Biochem Syst Ecol 36(4):266–282